Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
58%
Mouse
20%
Human Alphaherpesvirus 1
20%
Omicron Coronavirus Variant
17%
Viral Load
14%
COVID-19
14%
Influenza
13%
Virus Infectivity
12%
Lineages
11%
Vaccine Efficacy
11%
Viral Replication
10%
Dynamics
9%
Viral Disease
9%
Vaccination Policy
8%
Genomic Surveillance
8%
Breakthrough Infection
8%
Cycle Threshold
8%
Whole Genome Sequencing
8%
Infectious Agent
8%
Next Generation Sequencing
7%
T Cell
7%
Escherichia coli
7%
Orthopoxvirus
7%
Plasmid
7%
Cell Culture
7%
Wild Type
6%
Respiratory Virus
6%
Immune Response
6%
Upper Respiratory Tract
6%
Spike
6%
Droplet Digital Polymerase Chain Reaction
6%
Hemagglutinin
6%
Human Immunodeficiency Virus
5%
Monkeypox
5%
Pathogenicity
5%
Genotype
5%
Influenza B Virus
5%
Enterovirus D68
5%
Amino Terminal Sequence
5%
Sendai Virus
5%
Human Adenovirus C
5%
Explant
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
46%
Infection
44%
Diagnosis
14%
Outpatient
12%
Pathogen
10%
Omicron Coronavirus Variant
9%
Symptom
8%
Whole Genome Sequencing
8%
Coronavirinae
8%
Disease
7%
Virus Infectivity
6%
Severe Acute Respiratory Syndrome
6%
Quantitative Reverse Transcription Polymerase Chain Reaction
6%
Public Health
6%
Diagnostic Test
5%
Virus RNA
5%
Nasopharyngeal Swab
5%
Pandemic
5%
Human Adenovirus C
5%
Mixed Infection
5%
Influenza
5%
Human Immunodeficiency Virus
5%
Serositis
5%
Keyphrases
COVID-19
52%
Herpes Simplex Virus Type 1 (HSV-1)
20%
Maryland
14%
Virus
11%
Baltimore
10%
SARS-CoV-2 Infection
9%
Genomic Surveillance
9%
Viral Replication
9%
Mpox
8%
Infected Cell Protein 0
8%
Genome Sequencing
8%
Infectious Virus
7%
Point-of-care
7%
United States
7%
Cycle Threshold
6%
Clinical Outcomes
6%
Immunodeficient Mice
6%
Saliva
5%
COVID-19 Pandemic
5%
Unvaccinated
5%
E3 Ubiquitin Ligase
5%
Hospitalization
5%
Johns Hopkins
5%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
5%
Delta Variant
5%
Phosphorylation Sites
5%
Droplet Digital PCR (ddPCR)
5%
SARS-CoV-2 Variants
5%
Pregnant Women
5%
Multiplexing
5%
Respiratory Pathogens
5%
Human Adenovirus (HAdV)
5%
Orthopoxvirus
5%
Virus Infection
5%
Influenza B Virus
5%
Respiratory Viruses
5%
